Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masakuni Amari

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of Alzheimer'S Disease : JAD|October 11, 2021
Age-Related Cognitive Decline and Prevalence of Mild Cognitive Impairment in the Iwaki Health Promotion ProjectNaoko Nakahata, Takumi Nakamura, Takeshi Kawarabayashi, et al.
Eneurologicalsci|December 9, 2025
<sup>18</sup>F-MK-6240 uptake in cortical tau and hemorrhagic lesions in a case of Alzheimer's disease with possible crossed aphasiaMasaki Ikeda, Kenji Ishibashi, Masakuni Amari, et al.
Annals of Clinical and Translational Neurology|March 9, 2026
Clinical Validation of Plasma p-217tau in Neurological DiseasesTakeshi Kawarabayashi, Takumi Nakamura, Ryoma Takahashi, et al.
Journal of Alzheimer'S Disease : JAD|November 26, 2023
Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer's Disease or Other Neurological DiseasesTakeshi Kawarabayashi, Takumi Nakamura, Kazuya Miyashita, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 22, 2012
Encephalopathy with amyloid angiopathy and numerous amyloid plaques with low levels of CSF Aβ1-40/Aβ1-42Masaki Ikeda, Kimitoshi Hirayanagi, Motonobu Arai, et al.
Journal of Alzheimer'S Disease : JAD|January 2, 2026
Drebrin is a novel biomarker of cognitive deterioration in Alzheimer's diseaseMikio Shoji, Takeshi Kawarabayashi, Takumi Nakamura, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsTakeshi Kawarabayashi, Takumi Nakamura, Shin Takatama, et al.
Eneurologicalsci|June 24, 2024
A case of chronic progressive autoimmune GFAP astrocytopathy with extensive meningoencephalomyelitis and contrast enhancement on MRIHironori Oka, Takumi Nakamura, Takashi Sugawara, et al.
Journal of the Neurological Sciences|July 20, 2024
High levels of plasma neurofilament light chain correlated with brainstem and peripheral nerve damageTakumi Nakamura, Takeshi Kawarabayashi, Makoto Shibata, et al.
Neurobiology of Aging|June 24, 2004
Soluble Abeta homeostasis in AD and DS: impairment of anti-amyloidogenic protection by lipoproteinsEtsuro Matsubara, Yoshiki Sekijima, Takahiko Tokuda, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of Alzheimer'S Disease : JAD|October 11, 2021
Age-Related Cognitive Decline and Prevalence of Mild Cognitive Impairment in the Iwaki Health Promotion ProjectNaoko Nakahata, Takumi Nakamura, Takeshi Kawarabayashi, et al.
Eneurologicalsci|December 9, 2025
<sup>18</sup>F-MK-6240 uptake in cortical tau and hemorrhagic lesions in a case of Alzheimer's disease with possible crossed aphasiaMasaki Ikeda, Kenji Ishibashi, Masakuni Amari, et al.
Annals of Clinical and Translational Neurology|March 9, 2026
Clinical Validation of Plasma p-217tau in Neurological DiseasesTakeshi Kawarabayashi, Takumi Nakamura, Ryoma Takahashi, et al.
Journal of Alzheimer'S Disease : JAD|November 26, 2023
Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer's Disease or Other Neurological DiseasesTakeshi Kawarabayashi, Takumi Nakamura, Kazuya Miyashita, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 22, 2012
Encephalopathy with amyloid angiopathy and numerous amyloid plaques with low levels of CSF Aβ1-40/Aβ1-42Masaki Ikeda, Kimitoshi Hirayanagi, Motonobu Arai, et al.
Journal of Alzheimer'S Disease : JAD|January 2, 2026
Drebrin is a novel biomarker of cognitive deterioration in Alzheimer's diseaseMikio Shoji, Takeshi Kawarabayashi, Takumi Nakamura, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsTakeshi Kawarabayashi, Takumi Nakamura, Shin Takatama, et al.
Eneurologicalsci|June 24, 2024
A case of chronic progressive autoimmune GFAP astrocytopathy with extensive meningoencephalomyelitis and contrast enhancement on MRIHironori Oka, Takumi Nakamura, Takashi Sugawara, et al.
Journal of the Neurological Sciences|July 20, 2024
High levels of plasma neurofilament light chain correlated with brainstem and peripheral nerve damageTakumi Nakamura, Takeshi Kawarabayashi, Makoto Shibata, et al.
Neurobiology of Aging|June 24, 2004
Soluble Abeta homeostasis in AD and DS: impairment of anti-amyloidogenic protection by lipoproteinsEtsuro Matsubara, Yoshiki Sekijima, Takahiko Tokuda, et al.
Pageof 4